Icosavax, Inc.
(NASDAQ GS: ICVX)
Rigrodsky Law, P.A. is investigating Icosavax, Inc. (“Icosavax”) regarding possible breaches of fiduciary duties and other violations of law related to Icosavax’s agreement to be acquired by AstraZeneca. Under the terms of the agreement, Icosavax shareholders will receive $15.00 per share in cash.